top of page


Kolmar Can See the Fakes. It Can't Sue a Single One.
Kolmar Korea named overseas counterfeits as K-beauty's biggest problem. The manufacturer holds no trademark, and a US sunscreen is a drug, not a cosmetic.
Oct 216 min read


Clicks Didn't Just Buy 12 Arc Stores. It Bought a Multi-Million Dollar Blind Spot.
Korean cosmetics reached 202 countries in 2025, and the ten largest markets took 70.7% of an $11.4 billion total. No African market appears in the published breakdown. On 28 September 2026 Clicks Group agreed to pay R507 million, about $30.7 million, for control of ARC, a 12-store South African chain whose own K-Beauty page carries seventeen brands and whose newest arrivals are Korean. The shelf that Korea’s export table does not name is the one a retail group just bought.
Oct 116 min read


A Korean State Permit Is an American Lawsuit Waiting to Happen
South Korea licenses 11 functional cosmetic claim categories, like wrinkle care or UV protection. In contrast, the US FDA pre-approves no cosmetics. Under US law, functional claims alter a product's intended use—reclassifying a cosmetic as an unapproved drug. While MoCRA increases US facility listings, domestic Korean claims on exported goods still cause import detentions and refusals.
Sep 308 min read


K-Beauty Didn't Solve Coily Hair. It Moved to the Scalp
Bephor launched three products in South Africa on 14 September 2026: a no-rinse scalp cleansing toner, scalp cleansing toner pads, and a scalp sleeping oil balm. Every one of those formats is Korean skincare, relocated. None of them touches the hair shaft, which is the part of Type 4 hair that Korean formulation still does not serve well. The brand is filed under hair care, and hair care is 5.1 percent of Korea's cosmetics exports. What Bephor sells is skin. Skincare was 74
Sep 268 min read
bottom of page